Stay updated with breaking news from Technology Commercialization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
_cell_identifies_cancer_cell_-_Illustration_-_Alpha_Tauri_3D_Graphics_M1_df26c964f0144a8b912d9638f99be561-620x480.jpg)
Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.
Assistant professor Wubin Bai and his team have developed a novel, bioelectronic technology that will improve patients’ lives, helping to safely automate and lower the burden of post-recovery care.
Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at the Purdue University College of Pharmacy.
During the 2021-22 fiscal year, 13 startup companies executed agreements to access foundational intellectual property and commercialize new technologies developed at the University of California, Davis.
A fractional share allows an investor to own less than one full share of a stock. This can make investing more accessible and more affordable.